E. Jepson

748 total citations
20 papers, 388 citations indexed

About

E. Jepson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Jepson has authored 20 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Jepson's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diet and metabolism studies (3 papers) and Cholesterol and Lipid Metabolism (3 papers). E. Jepson is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diet and metabolism studies (3 papers) and Cholesterol and Lipid Metabolism (3 papers). E. Jepson collaborates with scholars based in United Kingdom and Ireland. E. Jepson's co-authors include B Slavin, David J. Reynolds, David Jenkins, Alexandra L. Jenkins, A. R. Leeds, J I Mann, David Jenkins, David B. Peterson, Stephen Young and J.K. Cruickshank and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Annals of the Rheumatic Diseases.

In The Last Decade

E. Jepson

19 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Jepson United Kingdom	10	148	125	107	96	91	20	388
B Slavin United Kingdom	9	150 1.0×	131 1.0×	96 0.9×	109 1.1×	123 1.4×	10	484
A Strata Italy	8	54 0.4×	73 0.6×	56 0.5×	61 0.6×	53 0.6×	22	355
Larry Bell United States	11	132 0.9×	94 0.8×	19 0.2×	98 1.0×	70 0.8×	15	511
S Lousley United Kingdom	6	177 1.2×	128 1.0×	40 0.4×	205 2.1×	60 0.7×	6	389
C E West Netherlands	9	131 0.9×	77 0.6×	40 0.4×	82 0.9×	53 0.6×	14	444
M Batlouni Brazil	9	67 0.5×	47 0.4×	56 0.5×	86 0.9×	45 0.5×	37	355
F. Godsey France	6	230 1.6×	73 0.6×	14 0.1×	50 0.5×	108 1.2×	6	343
B. S. Simic Serbia	2	212 1.4×	66 0.5×	21 0.2×	106 1.1×	77 0.8×	5	387
A. Boussairi France	7	217 1.5×	178 1.4×	34 0.3×	128 1.3×	52 0.6×	12	408
H. Bukowska Poland	10	114 0.8×	63 0.5×	111 1.0×	144 1.5×	55 0.6×	25	513

Countries citing papers authored by E. Jepson

Since Specialization

Citations

This map shows the geographic impact of E. Jepson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Jepson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Jepson more than expected).

Fields of papers citing papers by E. Jepson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Jepson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Jepson. The network helps show where E. Jepson may publish in the future.

Co-authorship network of co-authors of E. Jepson

This figure shows the co-authorship network connecting the top 25 collaborators of E. Jepson. A scholar is included among the top collaborators of E. Jepson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Jepson. E. Jepson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cruickshank, J.K., Naomi M. Anderson, J. Wadsworth, Stephen Young, & E. Jepson. (1988). Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.. BMJ. 297(6657). 1155–1159. 29 indexed citations

Tachakra, Sapal, et al.. (1988). Successful transcutaneous external pacing for asystole following cardiac arrest.. Emergency Medicine Journal. 5(3). 184–185. 6 indexed citations

Cruickshank, J.K., et al.. (1987). Treating Hypertensive Diabetics. Journal of Cardiovascular Pharmacology. 10. S85–86. 3 indexed citations

Peterson, David B., et al.. (1987). Low Dose Guar in a Novel Food Product: Improved Metabolic Control in Non‐insulin‐dependent Diabetes. Diabetic Medicine. 4(2). 111–115. 36 indexed citations

Cruickshank, J.K., et al.. (1987). Treating Hypertensive Diabetics. Journal of Cardiovascular Pharmacology. 10. S85–86. 4 indexed citations

Peterson, David B., et al.. (1986). Dietary practices of Asian diabetics.. BMJ. 292(6514). 170–171. 17 indexed citations

Jepson, E., et al.. (1985). Prevalence of known diabetes in Asians and Europeans. BMJ. 291(6508). 1572.1–1572. 1 indexed citations

Jenkins, David, David J. Reynolds, B Slavin, et al.. (1980). Dietary fiber and blood lipids: treatment of hypercholesterolemia with guar crispbread. American Journal of Clinical Nutrition. 33(3). 575–581. 131 indexed citations

Jenkins, David, et al.. (1979). Dietary fiber and blood lipids: reduction of serum cholesterol in type II hyperlipidemia by guar gum. American Journal of Clinical Nutrition. 32(1). 16–18. 83 indexed citations

10.

Jepson, E., et al.. (1972). A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias. Atherosclerosis. 16(1). 9–14. 5 indexed citations

11.

Billimoria, J.D., et al.. (1971). The use of the esterified fatty acid index in the classification and quantitation of hyperlipoproteinaemias. Atherosclerosis. 14(3). 359–374. 9 indexed citations

12.

Jepson, E., et al.. (1969). TREATMENT OF ESSENTIAL HYPERLIPIDÆMIA. The Lancet. 294(7634). 1315–1319. 16 indexed citations

13.

Gibberd, F B, et al.. (1965). Felty's Syndrome. Annals of the Rheumatic Diseases. 24(1). 46–51. 3 indexed citations

14.

Jepson, E., et al.. (1965). Estimation of blood glucose by the glucose oxidase strip method.. PubMed. 195(169). 643–7. 3 indexed citations

15.

Harris, E. A., et al.. (1964). CLINICAL PHARMACOLOGY. The Lancet. 283(7346). 1323–1325.

16.

Jepson, E.. (1963). Long-term Trial of D-Thyroxine in Hypercholesterolaemia. BMJ. 1(5343). 1446–1449. 11 indexed citations

17.

Jepson, E. & D. C. O. James. (1963). The treatment of hypercholesterolaemic xanthomatosis with atromid. Journal of Atherosclerosis Research. 3(5-6). 554–560. 12 indexed citations

18.

Jepson, E.. (1962). MER-29 (Triparanol) in the Control of Hypercholesterolæmia. Proceedings of the Royal Society of Medicine. 55(6). 480–484. 3 indexed citations

19.

Jepson, E.. (1961). Hypercholesterolaemic Xanthomatosis. BMJ. 1(5229). 847–853. 9 indexed citations

20.

Jepson, E., et al.. (1958). Thoracic Actinomycosis. BMJ. 1(5078). 1025–1027. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact